Back to BENJAMIN EDWARDS INC BENJAMIN EDWARDS INC

CRSPCRSP
30 quarters

Position history for BENJAMIN EDWARDS INCBENJAMIN EDWARDS INC's holdings in CRISPR THERAPEUTICS AG

BENJAMIN EDWARDS INC holds 54,488 shares of CRSP (CRISPR THERAPEUTICS AG), worth $3M as of 2026-Q2. The position was decreased (-1.8% shares). CRSP represents 0.0% of BENJAMIN EDWARDS INC's portfolio.

Current Value

$3M

Current Shares

54,488

Total Value Change

+$3M

Total Shares Change

+54,210

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
54,488
-1.8%
$3M0.0%$54.54
0
2026-Q1
Increased
55,506
+1.6%
$2.6M0.0%$58.06
27
2025-Q4
Increased
54,636
+0.8%
$2.9M0.0%$53.19
26
2025-Q3
Decreased
54,220
-6.1%
$3.5M0.0%$63.77
0
2025-Q2
Increased
57,760
+13.4%
$2.8M0.0%$47.49
30
2025-Q1
Increased
50,915
+13.0%
$1.7M0.0%$36.99
29
2024-Q4
Increased
45,062
+37.8%
$1.8M0.0%$38.65
34
2024-Q3
Increased
32,703
+136x
$1.5M0.0%$47.32
41
2024-Q2
Decreased
238
-35.5%
$130.0%$54.01
0
2024-Q1
Increased
369
+8.8%
$250.0%$68.16
12
2023-Q4
Decreased
339
-32.7%
$210.0%$62.60
0
2023-Q3
Increased
504
+2.6%
$230.0%$45.39
11
2023-Q2
Decreased
491
-12.0%
$280.0%$57.02
0
2023-Q1
Increased
558
+5.7%
$250.0%$44.16
12
2022-Q4
Increased
528
+25.4%
$210.0%$40.65
14
2022-Q3
Decreased
421
-15.6%
$28,0000.0%$64.49
0
2022-Q2
Increased
499
+4.0%
$30,0000.0%$63.00
20
2022-Q1
Increased
480
+2.1%
$30,0000.0%$64.08
20
2021-Q4
Increased
470
+18.7%
$36,0000.0%$78.85
23
2021-Q3
Decreased
396
-3.4%
$44,0000.0%$110.20
0
2021-Q2
Decreased
410
-14.2%
$66,0000.0%$150.49
0
2021-Q1
Decreased
478
-12.3%
$58,0000.0%$115.20
0
2020-Q4
Decreased
545
-29.9%
$83,0000.1%$161.57
0
2020-Q3
Increased
778
+6.6%
$65,0000.1%$84.99
22
2020-Q2
Unchanged
730
0.0%
$54,0000.0%$75.05
0
2020-Q1
Increased
730
+17.6%
$31,0000.0%$44.29
23
2019-Q4
Increased
621
+9.5%
$38,0000.1%$61.84
22
2019-Q3
Increased
567
+3.9%
$23,0000.0%$42.36
20
2019-Q2
Increased
546
+96.4%
$26,0000.1%$47.10
31
2019-Q1
New
278
-
$10,0000.0%$35.72
24

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used